Hematology

Gynecologic Cancers

Questions discussed in this category

What strategies have you found to be most effective in engaging PCPs in a primary-care or shared-care model of survivorship for pediatric and AYA patients who will receive ongoing care in their communities away from their primary oncology treatment site?

In follow up to @Jacqueline Casillas presentation at ASCO 2021 regarding models of survivorship care delivery for AYA patients.

1 Answer available

What are the current official guidelines regarding COVID-19 vaccination for patients with cancer or for hematologic conditions?

2 Answers available

How do you counsel patients who are candidates for a clinical trial regarding their options?

Specifically, are there strategies you use to 1) empower patients to participate in decision-making and 2) reassure patients who may be skeptical?

2 Answers available

Do you routinely prophylactically anticoagulate patients undergoing systemic chemotherapy outside of the perioperative period?

1 Answer available

Papers discussed in this category

Blood, 2008-05-15

Development and validation of a predictive model for chemotherapy-associated thrombosis.

The New England journal of medicine, 2019-02-21

Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer.

J Thromb Haemost, 2019 Jul 28

The use of direct oral anticoagulants for primary thromboprophylaxis in ambulatory cancer patients: Guidance from the SSC of the ISTH.

N Engl J Med, 2018 Dec 04

Apixaban to Prevent Venous Thromboembolism in Patients with Cancer.

Related Topics in Hematology